marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
"the big unanswered question is concerns over safety in pregnancy," she says. cgrp levels are lower than normal in pregnant women who have.notify me of new posts via email... .. march 2017 (21).